{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:42:42Z","timestamp":1789832562422,"version":"4.0.1"},"reference-count":0,"publisher":"Clinical and Experimental Rheumatology","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.55563\/clinexprheumatol\/eeglsa","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T15:08:10Z","timestamp":1721056090000},"source":"Crossref","is-referenced-by-count":13,"title":["Brepocitinib, a potent and selective TYK2\/JAK1 inhibitor: scientific and clinical rationale for dermatomyositis"],"prefix":"10.55563","author":[{"given":"Julie J.","family":"Paik","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jpaik1@jhmi.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Vencovsky\u0301","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology and Department of Rheumatology, 1st Medical Faculty, Charles University, Prague, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Charles-Schoeman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of California, Los Angeles School of Medicine, Los Angeles, CA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.","family":"Wright","sequence":"additional","affiliation":[{"name":"Association of Women in Rheumatology, New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra S.","family":"Goriounova","sequence":"additional","affiliation":[{"name":"Priovant Therapeutics Inc., New York, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Mudd, Jr","sequence":"additional","affiliation":[{"name":"Priovant Therapeutics Inc., New York, NY, USA. paul.mudd@priovanttx.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"34330","published-online":{"date-parts":[[2024,3,23]]},"container-title":["Clinical and Experimental Rheumatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T15:08:13Z","timestamp":1721056093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.clinexprheumatol.org\/abstract.asp?a=21096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,23]]},"references-count":0,"alternative-id":["CER17712"],"URL":"https:\/\/doi.org\/10.55563\/clinexprheumatol\/eeglsa","relation":{},"ISSN":["1593-098X"],"issn-type":[{"value":"1593-098X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,23]]}}}